European Investment Bank

Orano is a leading global company based in Courbevoie, France, specializing in nuclear power and renewable energy solutions. The company offers a comprehensive range of services covering every stage of the nuclear fuel cycle, including reactor design, construction, and operational support. With a strong emphasis on safety and advanced technology, Orano is committed to supplying low-carbon power generation solutions. Additionally, it engages in renewable energy initiatives through partnerships aimed at developing high-tech solutions. As energy demand increases and the need for sustainable practices intensifies, Orano focuses on creating cleaner energy alternatives that contribute to reducing greenhouse gas emissions. The company aims to enhance transparency, coherence, and efficiency in its operations while preparing for the future energy landscape.

Royal Schiphol Group N.V. is the owner and operator of Amsterdam Airport Schiphol, the national airport of the Netherlands, as well as other airports including Rotterdam The Hague Airport and Lelystad Airport. The company manages and develops airport operations, providing essential services and facilities to airlines, travelers, handling agents, and logistics providers. It also grants concessions for various shops, restaurants, and entertainment options within the airport, while operating its own retail spaces and car parks. Additionally, Royal Schiphol Group develops and manages properties related to airport activities, offering various locations and rental agreements for businesses and logistics service providers. Established in 1958 and headquartered in Schiphol, the company plays a crucial role in aviation and transportation in the Netherlands and beyond.

Samotics is a Dutch technology company that specializes in an AI-powered condition monitoring platform aimed at enhancing the availability of industrial electric motors and rotating equipment. By utilizing data from sensors and operational systems, Samotics' solution offers predictive insights that help companies identify and address potential equipment failures before they occur. This proactive approach enables organizations to reduce unplanned downtime, lower operational costs, and minimize energy waste. The company serves a diverse range of global industrial clients, including notable names such as Anglian Water, ArcelorMittal, and Nobian, helping them optimize their operations and improve the efficiency of their critical equipment.

NXP Semiconductors N.V. is a prominent supplier of high-performance mixed-signal semiconductor products, headquartered in Eindhoven, the Netherlands. Founded in 2006, the company offers a diverse product portfolio that includes microcontrollers, application processors, communication processors, and various wireless connectivity solutions such as Bluetooth, Wi-Fi, and Near Field Communications. NXP's technology is integral to multiple applications across automotive, industrial, Internet of Things, mobile, and communication infrastructure sectors. The company has established a significant presence in the automotive market, providing essential components for powertrains, infotainment systems, and safety systems. Additionally, NXP maintains operations in over 25 countries and has formed strategic partnerships, including collaboration with Amazon Web Services to enhance connected vehicle solutions.

EDP Renewables (Euronext: EDPR) is a , global renewable energy company devoted to value creation, innovation and sustainability. They operate in markets around the globe and are continuously expanding their business to new regions, making the commitment to lead in each market as well as create value for their stakeholders and shareholders. EDPR has developed wind farms since 1996 and was first listed publicly in June 2008. EDPR’s global presence is managed by two regional platforms which oversee the development, construction and operation of assets in their geographic areas. EDPR Europe, headquartered in Madrid, manages assets located in the European Union, and other Regions renewable energy assets of the EDP Group and EDPR North America, headquartered in Houston, manages assets in the United States and Canada. EDPR is committed to operational excellence through high-quality assets and attractive markets which provide highly attractive possibilities, principally due to their growth prospects and stable regulatory structure that permit profit generation. Energias de Portugal, S.A. (“EDP”), a vertically-integrated utility company, headquartered in Lisbon, Portugal, is the majority shareholder of EDPR. EDP Group is Portugal´s largest industrial group and one of Europe´s primary energy companies. Currently, it is the Iberian Peninsula´s third largest energy operator with business interests in generation, distribution and supply of electricity and gas in Portugal and Spain. Additional to its leadership position in the Iberian Peninsula, EDP Group also holds a significant position in the Brazilian electricity sector

EDP ​​is a global energy company in value creation, innovation and sustainability. They include in their cultural values and commitments regarding their customers, society, and environment. Their vision to be an integrated energy company, a leader in value creation in the markets where they can make a difference is shared by the universe of EDP employees, spread across different continents and countries, a diversity that enriches us and brings us together in the respect for the different cultures of the markets where they operate. They are among the major European operators in the energy sector; they are one of the largest energy operators of the Iberian Peninsula, the largest Portuguese industrial group and the 3rd largest producer of wind energy. Besides the electricity sector - generation, distribution, and trading - they also have a significant presence in the gas sector of the Iberian Peninsula. They integrate the Dow Jones Sustainability Indexes (World and STOXX), the world's most demanding ranking, that distinguishes the best-performing companies on issues related to transparency, sustainability, and excellence in economic management and social environment. EDP was founded in 1976 and is headquartered in Lisboa, Portugal.

Cellectis S.A. is a clinical-stage biotechnological company headquartered in Paris, France, focused on developing immuno-oncology products utilizing gene-edited T-cells that express chimeric antigen receptors to target cancer cells. The company's primary portfolio includes several allogeneic T-cell product candidates such as UCART19, designed for treating CD19-expressing hematologic malignancies, and UCART123 for acute myeloid leukemia. Additional candidates include ALLO-501 for relapsed/refractory diffuse large B-cell lymphoma, UCART22 for B-cell acute lymphoblastic leukemia, and products targeting multiple myeloma, such as UCARTCS1 and ALLO-715. In addition to its therapeutic developments, Cellectis also produces high oleic soybean oil and other agricultural products. The company has established strategic partnerships with various institutions, including Allogene Therapeutics and The University of Texas M.D. Anderson Cancer Center. Founded in 1999, Cellectis continues to innovate in the field of gene editing and immunotherapy.

Marinomed is a biopharmaceutical development company focusing on the development of innovative therapies based on patent protected technology platforms. Products against respiratory viruses derived from the proprietary MAVIREX platform are marketed with renowned partners in a growing number of countries around the globe. The new MARINOSOLV platform allows novel stable aqueous formulations of hardly soluble compounds such as corticosteroids, enabling a faster onset of action and a better bioavailability. The MARINOSOLV technology is not limited to a specific compound and has the potential to facilitate delivery of any compound with solubility issues. Marinomed was founded on 2006 and is headquartered in Vienna, Austria.

Enpal GmbH, founded in 2017 and based in Berlin, Germany, specializes in providing all-in-one renewable energy solutions, including solar panels, battery systems, wallboxes, heat pumps, and energy management systems. The company focuses on making renewable energy accessible and affordable for customers in Germany and Italy through a unique leasing model that requires no upfront payment. This model covers installation, insurance, and maintenance, attracting customers who prefer to avoid high initial investments. Enpal has successfully installed over 60,000 solar photovoltaic systems, becoming the market leader in Germany. The company employs more than 1,000 staff, including over 200 local installer teams, and has opened several satellite offices to enhance customer service. Enpal has received numerous accolades, including awards for sustainability and customer service. In recent years, it has diversified its offerings and introduced a sales option to accommodate customers interested in purchasing their solar solutions. In 2022, Enpal reported revenues exceeding 400 million euros and has been recognized as one of Germany's fastest-growing companies.

Polski Koncern Naftowy Orlen is a prominent energy conglomerate operating primarily in the oil and gas sector. The company refines and distributes oil in Poland, the Czech Republic, Germany, and Lithuania, processing crude oil into various products such as gasoline, diesel, fuel oil, and aviation fuel through its network of refineries. In addition to refining, Orlen produces petrochemicals and chemical feedstock. The company is also involved in exploration and production activities in Poland and Canada. Orlen's extensive logistics infrastructure supports its operations, featuring both surface and underground storage depots, as well as a long-distance pipeline network, which facilitates the distribution of oil products through a widespread network of service stations.

NVision Imaging Technologies GmbH, founded in 2015 and based in Ulm, Germany, specializes in the development and commercialization of innovative imaging and sensing applications grounded in quantum physics. The company has created a platform that polarizes natural metabolites, enabling their use as agents for imaging tumor metabolism through magnetic resonance imaging (MRI). This technology transforms standard magnetic resonance spectrometers into tools capable of assessing human metabolism, thereby enhancing the precision of cancer diagnostics and facilitating real-time monitoring of patient responses to therapy. By leveraging advances in quantum physics, NVision aims to make significant strides in the medical imaging and diagnostics sector.

Deutsche Glasfaser Holding GmbH, founded in 2012 and based in Borken, Germany, specializes in the planning, construction, and operation of fiber optic networks, particularly targeting rural and suburban areas. As a significant player in the broadband telecommunications sector, the company aims to facilitate nationwide fiber optic expansion, contributing to Germany's digital advancement. Deutsche Glasfaser focuses on delivering fast and cost-effective fiber-to-the-home (FTTH) connections in collaboration with municipalities, positioning itself as a leader in innovative planning and construction processes. With substantial backing from experienced investors, the company has established a strong financial foundation, making it one of the most robust providers in the German market.

Protembis GmbH, founded in 2017 and based in Aachen, Germany, specializes in the manufacture of surgical equipment aimed at enhancing the safety of transcatheter aortic valve replacement (TAVR) procedures. The company has developed the ProtEmbo System, an intra-aortic filter device designed to mitigate the risk of cerebrovascular events during TAVR by deflecting embolic material away from the cerebral circulation. This innovation addresses a significant complication associated with TAVR, which has become a preferred treatment for patients with valvular heart disease, particularly as the procedure is increasingly performed on younger and lower-risk individuals. By minimizing the risk of brain injury, Protembis aims to improve patient outcomes and reduce healthcare costs related to surgical complications.

Nyxoah S.A. is a health-technology company based in Mont-Saint-Guibert, Belgium, established in 2009. The company specializes in developing and commercializing innovative solutions for treating sleep disordered breathing conditions, particularly moderate to severe obstructive sleep apnea (OSA). Its primary product, the Genio system, is a user-centered, bilateral neurostimulation therapy that has received CE-Mark validation. OSA is a prevalent condition linked to significant health risks, including increased mortality and various comorbidities such as cardiovascular diseases, depression, and stroke. Nyxoah aims to address these critical health challenges through its advanced therapeutic offerings.

XOCEAN Limited specializes in providing comprehensive ocean data solutions through uncrewed surface vessels (USVs). Founded in 2017 and based in Greenore, Ireland, the company offers a Data Collection-as-a-Service model aimed at surveyors, agencies, universities, and research institutions. XOCEAN's USVs enable unmanned operations over the horizon, utilizing satellite communications for effective data collection. The company also features the XOCEAN CyberDeck, a secure cloud-based platform that allows for real-time monitoring and control of USVs, while ensuring data quality through adjustable parameters. XOCEAN's services encompass a variety of applications, including seabed mapping, fisheries, bathymetry, met ocean data, and environmental monitoring, catering to clients in offshore industries, government bodies, and the renewables sector. The integration of standard survey systems and onboard computing capabilities further enhances the efficiency and effectiveness of their data acquisition processes.

Intrinsic ID B.V. specializes in digital authentication solutions, primarily utilizing its proprietary SRAM Physical Unclonable Function (SRAM PUF) technology. Founded in 2008 and based in Eindhoven, the Netherlands, with operations in Korea, the company develops a range of products aimed at enhancing security for Internet of Things (IoT) and embedded applications. Its offerings include Broadkey, a secure key management software; Citadel, a key provisioning system; Quiddicard, which focuses on remotely programming keys; and Quiddikey, a solution for reconstructing on-chip secret keys without storage. These technologies are designed to validate payment systems, secure connectivity, authenticate sensors, and safeguard sensitive government and military data and systems.

Evonik Industries AG is a leading German chemical company specializing in the production of specialty chemicals used across various industries, including nutrition, healthcare, and resource efficiency. The company operates in over 100 countries and is a market leader in approximately 80% of its business segments, which include specialty additives, smart materials, nutrition and care, and performance materials. Evonik's innovative approaches and integrated technology platforms enable it to offer diverse products, such as animal nutrition, high-performance polymers, and sustainable solutions. With a strong presence in Europe, North America, and Asia, Evonik generates a significant portion of its revenue from these key markets. The company continues to focus on addressing megatrends such as health, nutrition, and sustainability, positioning itself for ongoing growth and leadership in the specialty chemicals sector.

ABN AMRO Bank N.V., headquartered in Amsterdam, is one of the largest banks in the Netherlands, providing a comprehensive range of financial services to retail, private, and commercial clients both domestically and internationally. The bank's offerings include advanced mobile applications and Internet banking, facilitating seamless customer access to financial products. Its investment banking division specializes in mergers and acquisitions advisory, corporate advisory, portfolio management, and various financing solutions. Additionally, ABN AMRO Ventures, the bank's venture capital arm, focuses on investing in startups that promote innovative payment methods and the digitization of financial services, investing amounts typically ranging from $0.26 million to $1.59 million. The bank emphasizes integrity, transparency, and accountability within its corporate governance, ensuring effective risk management and compliance with regulations. The governance structure comprises a two-tier model, including a Supervisory Board and a Managing Board, which oversee the bank's operations and strategic direction.

Volvo Car Group, known for its premium automobiles, has a rich history dating back to 1927 when it produced its first car in Gothenburg. Today, it operates globally, selling vehicles in approximately 100 countries, with significant markets in the United States, Sweden, China, Germany, and the United Kingdom. Owned by Zhejiang Geely Holding of China since 2010, Volvo manufactures a diverse range of vehicles, including sedans, SUVs, estates, and convertibles, all characterized by their Scandinavian design and focus on human-centric functionality. The company's brand strategy, "Designed Around You," emphasizes customer needs and sustainable mobility solutions, such as plug-in hybrids and electric vehicles. Volvo Car is dedicated to innovation, continually developing technologies that enhance safety and simplify the driving experience while contributing to a more sustainable society. With headquarters in Mahwah, New Jersey, Volvo Car remains committed to delivering high-quality automobiles that embody craftsmanship and advanced engineering.

Zealand Pharma A/S is a biotechnology company based in Copenhagen, Denmark, specializing in the discovery and development of peptide-based medicines. The company has a robust proprietary pipeline that includes several clinical candidates such as glepaglutide for short bowel syndrome and dasiglucagon for diabetes management and congenital hyperinsulinism. Zealand's first marketed product, lixisenatide, is a once-daily prandial GLP-1 analogue for Type 2 diabetes, available globally outside the U.S. through a collaboration with Sanofi. Additionally, Zealand has engaged in licensing collaborations with prominent pharmaceutical companies, including Sanofi, Helsinn Healthcare, and Boehringer Ingelheim, to advance its clinical programs and expand its portfolio. The company is committed to developing innovative therapies aimed at addressing unmet medical needs in various therapeutic areas.

INBRAIN Neuroelectronics is a medical device company based in Barcelona, Spain, that specializes in developing graphene-based neural interfaces and intelligent neuromodulation systems aimed at treating brain disorders. Founded in 2019, the company offers the world's first brain-computer interface (BCI) therapeutics platform, which integrates precise BCI decoding with micrometric modulation to provide adaptive and personalized treatments for conditions such as Parkinson's disease, epilepsy, and stroke rehabilitation. Its technology enables continuous real-time monitoring and autonomous adjustments to therapy, enhancing therapeutic outcomes while reducing side effects. INBRAIN is also engaged in strategic collaborations, including with Merck KGaA, to expand its innovative solutions into peripheral nerve and systemic disease applications, thereby advancing the field of neurotechnology and bioelectronics.

VoltStorage GmbH, based in Olching, Germany, specializes in developing and producing power storage devices that utilize eco-friendly redox flow technology. The company's flagship product, VoltStorage, is a vanadium redox flow battery system designed to store excess electricity generated by solar panels during the day for use at night. This innovative approach enables homeowners to access renewable energy around the clock, promoting sustainability and environmental responsibility. In addition to its products, VoltStorage offers installation and technical support services, ensuring customers can effectively integrate these systems into their homes. The company aims to make renewable energy more accessible and contribute to a cleaner, fairer world for future generations.

Repsol is a Spanish integrated energy company that specializes in oil and gas production, as well as renewable energy solutions. With a daily production of 599,000 barrels of oil equivalent and proven reserves totaling 1.8 billion barrels, Repsol maintains a significant presence in the global energy market. The company operates a downstream segment with a refining capacity of 1 million barrels per day, complementing its upstream activities. Repsol is also focused on innovation and sustainable energy, having developed a renewable power generation capacity of 2.8 gigawatts. With operations in key energy regions such as Brazil, Russia, and the United States, Repsol is dedicated to creating a new energy model that encompasses both traditional and renewable energy sources.

Endesa is an electric utility company headquartered in Madrid, Spain, that generates, distributes, and supplies electricity primarily in Spain and Portugal. Founded in 1944, the company has an installed generation capacity of 22 gigawatts, utilizing a diverse mix of energy sources, including hydroelectric, nuclear, coal, natural gas, oil, solar, and wind. Endesa serves approximately 11.2 million customers and employs over 10,000 people. In addition to its core electricity services, Endesa operates in the natural gas sector and provides energy-related services, emphasizing a commitment to sustainability and technological innovation to address current and future energy challenges. The company also supplies gas to retail and business customers in Spain and France.

University College Cork is a prominent higher education institution located in Cork, Ireland, established in 1845. The university offers a diverse range of courses, encompassing fields such as Accounting, Zoology, and many others, catering to a broad spectrum of academic interests. Positioned dramatically on a limestone bluff, the campus provides an inspiring environment for students. University College Cork aims to address the evolving needs of higher education in Ireland, reflecting its commitment to fostering academic development and innovation. The institution's assets are overseen by a dedicated executive management team, ensuring effective governance and operational efficiency.

Trucksters is a Madrid-based freight startup that provides long-haul transport services through a unique relay system. This innovative approach utilizes big data and artificial intelligence to enhance the efficiency of long-distance road transit. By implementing relays, Trucksters enables trucks to remain in continuous motion, significantly reducing delivery times and transportation costs. The company operates throughout the European Union and serves over 500 shippers, contributing to the electrification agenda and improving the working conditions for drivers. Through its advanced logistics solutions, Trucksters aims to optimize the global road freight industry.

Iberdrola is a leading global utility company engaged in the production, distribution, and retail of electricity and gas across nearly 40 countries. With a diverse portfolio of 56 gigawatts, it primarily generates electricity from nuclear, fossil-fuel, hydroelectric, and renewable energy sources, with wind power representing approximately 40% of its capacity. The company operates significant electricity and distribution networks in Spain, the UK, Brazil, and the US, where it maintains a strong presence. Iberdrola is committed to advancing the energy transition through a sustainable business model that emphasizes renewable energy, smart grids, large-scale energy storage, and digital transformation, aimed at delivering innovative products and services to its customers. In addition to its generation activities, Iberdrola is involved in gas storage and supply, reinforcing its position as a comprehensive energy provider.

Wingcopter GmbH, founded in 2014 and based in Darmstadt, Germany, specializes in the development and manufacture of advanced delivery drones for various applications, including medical supply chains and last-mile logistics. The company produces eVTOL, fixed-wing unmanned aircraft systems designed to efficiently deliver medicines, vaccines, blood, lab samples, parcels, and food to remote locations, as well as conduct inspections of public infrastructure. Its flagship model, the Wingcopter 198, features a patented tilt-rotor mechanism that allows for vertical takeoff and landing while maintaining the efficiency and range of a fixed-wing aircraft, even under challenging weather conditions. With a dedicated team of 120 professionals, Wingcopter aims to enhance and save lives through both commercial and humanitarian efforts, earning recognition as a Technology Pioneer by the World Economic Forum in 2020.

AT&S is a Europe-based printed circuit board manufacturer focused on high-end printed circuit board technology. Depending on technological and economic requirements, the company offers the widest possible range of printed circuit boards specially tailored to customers’ needs such as double-sided plated-through, multi-layer, high density interconnection and laser-drilled, insulated metallic substrate, flexible, rigid-flex, and semi-flexible. The core businesses of AT&S are mobile devices and substrates, automotive, industrial, medical, aviation, and advanced packaging. It has approximately 7,300 employees, of which around 1,200 are in Austria. In the 2013 and 2014 financial year AT&S’s sales revenues totaled 590 million euros, and earnings before interest and tax were 53.9 million euros. AT&S is headquartered in Leoben, Austria.

Smart Reporting GmbH is a Munich-based company that specializes in providing an online platform for structured medical reporting, primarily targeting radiology and pathology. Founded in 2014, the company offers an intelligent software solution that aids physicians in generating high-quality medical reports. The platform features automatic text suggestions, medically accurate terminology, and targeted illustrations, ensuring reports meet established guidelines. Additionally, Smart Reporting assists hospitals and medical practices in implementing report quality standards, optimizing report templates, and integrating with existing systems. The company also provides advanced statistical tools for quality assurance, multilingual reporting, and customizable templates. Furthermore, it offers solutions for medical registries and clinical studies, enabling simultaneous report generation and data submission while facilitating systematic quality assurance. Overall, Smart Reporting enhances the efficiency and quality of medical reporting, ultimately improving communication within healthcare settings.

SiPearl is a French semiconductor company established in 2019, headquartered in Maisons-Laffitte, Île-de-France, with research and development centers located in France, Germany, and Spain. The company specializes in the design of high-performance, low-power microprocessors intended for exascale supercomputers, aligning its product development with the European Union’s technological goals. Its first microprocessor range, Rhea, is set for commercialization in early 2024 and is based on the Arm Neoverse V1 architecture. SiPearl is committed to manufacturing Rhea using advanced processes from TSMC, ensuring state-of-the-art performance. The microprocessors are aimed at a variety of applications, including computing, artificial intelligence, medical research, climate change mitigation, and energy management, serving scientific researchers and major players in the IT, electronics, and automotive sectors.

Reden Solar specializes in the development, financing, construction, and operation of solar photovoltaic power plants across Europe and Latin America. With an installed portfolio of 762 megawatts and an additional 15 gigawatts under development, the company primarily focuses on markets in France and Spain, while also expanding its operations in Greece and Italy. Reden Solar provides a variety of photovoltaic solutions, including agricultural greenhouses, ground-mounted systems, shelters, and rooftop installations, aimed at promoting sustainable energy production and contributing to environmental conservation.

GeNeuro is a biotechnology company based in Plan-Les-Ouates, Switzerland, specializing in the development of therapeutic drugs for diseases linked to pathogenic proteins originating from human endogenous retroviruses. The company primarily targets nervous system disorders, including multiple sclerosis and schizophrenia. Its lead product, GNbAC1, is a therapeutic monoclonal antibody designed to treat multiple sclerosis, while temelimab is another candidate that neutralizes a pathogenic protein from the HERV-W family. Additionally, GeNeuro is engaged in developing diagnostic tests to measure multiple sclerosis-associated retrovirus-ENV proteins in patients. Founded in 2006, the company is committed to addressing the underlying factors that drive the progression of neurodegenerative and autoimmune diseases.

Orange is a digital operator that offers mobile and internet services in Europe and Africa, and corporate telecommunication services worldwide. The group operates under the brand name Orange Business Services, both in France and internationally, in the business communication and IT services markets. Orange Business Services offers a range of services to large corporates, local authorities, and SMEs in France, as well as to multinationals around the world, supporting the implementation of their communication projects. To do so, OBS offers a full range of voice and data, IT, and integrated services. The Orange Fabs is an international network of startup drivers that provides startups in the digital space with advice, training, and events, as well as resources and expertise. Orange was founded in 1991 and is headquartered in Paris, France with a presence in 30 countries.

Iberdrola is a leading global utility company engaged in the production, distribution, and retail of electricity and gas across nearly 40 countries. With a diverse portfolio of 56 gigawatts, it primarily generates electricity from nuclear, fossil-fuel, hydroelectric, and renewable energy sources, with wind power representing approximately 40% of its capacity. The company operates significant electricity and distribution networks in Spain, the UK, Brazil, and the US, where it maintains a strong presence. Iberdrola is committed to advancing the energy transition through a sustainable business model that emphasizes renewable energy, smart grids, large-scale energy storage, and digital transformation, aimed at delivering innovative products and services to its customers. In addition to its generation activities, Iberdrola is involved in gas storage and supply, reinforcing its position as a comprehensive energy provider.

AB Science is a France-based pharmaceutical company founded in 2001 by a team of researchers, clinicians, and entrepreneurs. It specializes in the research, discovery, development, and marketing of protein kinase inhibitors, focusing on targeted therapies using tyrosine kinase inhibitors. The company aims to address significant unmet medical needs in various fields, including cancer, chronic inflammatory diseases, neurological degenerative disorders, and central nervous system diseases. AB Science is committed to innovating and developing new drugs that can significantly improve the lives of patients and enhance treatment outcomes in both human and veterinary medicine.

Power Capital Renewable Energy Limited, founded in 2011 and based in Dublin, Ireland, focuses on the development, operation, and management of large-scale photovoltaic solar farms. The company specializes in all four stages of a solar asset's life cycle, including design, development, financing, construction, and operation. By acquiring and managing utility-scale solar parks, Power Capital aims to provide clean and reliable energy, contributing to the sustainability of the renewable energy sector. Their commitment to delivering competitive and sustainable energy solutions positions them as a significant player in the renewable energy market.

ExeVir Bio BV, founded in 2020 and based in Zwijnaarde, Belgium, specializes in developing single-domain antibody-based therapies aimed at combating viral infections. The company leverages a llama-derived antibody technology platform to create robust antiviral treatments that offer broad protection against coronaviruses. Notably, it is developing VHH72-FC, an antibody that targets a highly conserved region on the spikes of SARS-CoV-2, crucial for the virus's entry into human cells. ExeVir Bio's rapid response platform for antivirals allows for an agile approach to emerging health threats, enabling the swift generation of drug candidates. The therapeutics produced through this innovative technology are designed to be stable, cost-effective, and accessible on a global scale.

Cellectis S.A. is a clinical-stage biotechnological company headquartered in Paris, France, focused on developing immuno-oncology products utilizing gene-edited T-cells that express chimeric antigen receptors to target cancer cells. The company's primary portfolio includes several allogeneic T-cell product candidates such as UCART19, designed for treating CD19-expressing hematologic malignancies, and UCART123 for acute myeloid leukemia. Additional candidates include ALLO-501 for relapsed/refractory diffuse large B-cell lymphoma, UCART22 for B-cell acute lymphoblastic leukemia, and products targeting multiple myeloma, such as UCARTCS1 and ALLO-715. In addition to its therapeutic developments, Cellectis also produces high oleic soybean oil and other agricultural products. The company has established strategic partnerships with various institutions, including Allogene Therapeutics and The University of Texas M.D. Anderson Cancer Center. Founded in 1999, Cellectis continues to innovate in the field of gene editing and immunotherapy.

numares AG is a German company specializing in the development and marketing of software-based test systems for clinical diagnostics and life science research. Founded in 2004 and based in Regensburg, the company utilizes nuclear magnetic resonance (NMR) spectroscopy and machine learning to analyze metabolomic networks. Its AXINON in vitro diagnostic system produces numeric spectra that provide critical information regarding patients' disease statuses, particularly in the fields of cardiovascular diseases, nephrology, oncology, and neurology. By employing magnetic group signaling (MGS) technology, numares AG offers a reliable, efficient, and cost-effective solution for NMR-based diagnostics, positioning itself as a leader in commercial NMR analytics in Europe while providing expert support to its customers.

Advicenne is a late-stage biopharmaceutical company founded in 2007 and headquartered in Nîmes, France. The company focuses on developing and commercializing innovative treatments for unmet medical needs in nephrology, particularly targeting orphan renal diseases and niche neurology indications. Its lead drug candidate, ADV7103, is undergoing late-stage clinical trials for two specific conditions: distal renal tubular acidosis (dRTA) and cystinuria. Advicenne aims to create pediatric-friendly therapeutics that enhance the lives of patients from early childhood through adulthood.

OVH APAC is a leading cloud provider known for its innovative and cost-effective solutions tailored for a diverse clientele, ranging from startups to large enterprises. Founded in 1999 by Octave Klaba and based in France, OVH offers a comprehensive portfolio of services, including web hosting, dedicated servers, cloud solutions, domain registration, and VOIP telephony. The company distinguishes itself through its proprietary global fiber-optic network and green data centers, which enable optimal performance and reliability. With a commitment to research and development and complete control over its supply chain, OVH delivers high-quality products and exceptional customer service. Additionally, OVH has established a strong partnership with VMware, integrating advanced software solutions to enhance network performance and streamline service delivery for its customers. As a result, OVH is recognized as one of the top internet hosting companies globally, serving millions of customers with cutting-edge technology and expertise.

GomSpace is a Danish space company established in 2007, specializing in the development and commercialization of nano-satellites. The company provides turn-key solutions tailored for various applications, including Internet of Things (IoT), communication, tracking, surveillance, and remote sensing. GomSpace offers a range of products, such as professional nano-satellite solutions, platforms, commercial off-the-shelf subsystems, software modules, and payloads designed to meet specific customer needs. Its business extends across multiple sectors, including academia, commercial enterprises, defense, and scientific research, with operations in Denmark, Sweden, other parts of Europe, the United States, Asia, and worldwide.

Energiefonds Overijssel is a venture capital firm established in 2012 and located in Zwolle, Netherlands. The company is dedicated to supporting the energy transition by providing financial contributions to initiatives and businesses that focus on energy savings or the generation of energy from renewable sources. Backed by the government, Energiefonds Overijssel prioritizes investments in renewable energy and clean energy technology, aiming to foster sustainable practices and innovation within the energy sector.

GenSight Biologics S.A. is a clinical-stage biotechnology company based in Paris, France, focused on developing gene therapy treatments for retinal degenerative diseases and neurodegenerative conditions affecting the central nervous system. Utilizing its core technology platforms—Mitochondrial Targeting Sequence and Optogenetics—the company aims to preserve and restore vision in patients with severe retinal disorders. Its lead product candidates include GS010, an AAV2-based gene therapy currently in Phase III trials for treating Leber hereditary optic neuropathy caused by mutations in the ND4 gene, and GS030, which is undergoing Phase I/II trials for retinitis pigmentosa and geographic atrophy in dry age-related macular degeneration. In addition to these, GenSight is advancing several products in preclinical stages targeting various ophthalmic and neurodegenerative diseases. Founded in 2012, the company is dedicated to innovative approaches that aim to prevent vision loss and improve the quality of life for affected patients.

SpinDiag GmbH is a medical technology company based in Freiburg, Germany, focused on developing automated point-of-care systems for the rapid and reliable detection of infectious diseases. Founded in 2016, the company has created a centrifugal-microfluidic test system that allows healthcare providers to screen for the 25 most common antibiotic resistances directly from patient samples upon hospital admission. This innovative system helps prevent the spread of drug-resistant bacteria by enabling the immediate isolation of infected patients. SpinDiag's first product is an automated SARS-CoV-2 test that provides laboratory-grade PCR results directly from standard patient swab samples, streamlining the workflow for nurses and integrating seamlessly into clinical practice. The fully automated system eliminates the need for manual pipetting, thereby minimizing the risk of infection and enhancing the efficiency of pathogen detection in hospital settings.

MithraSol specialises in the identification, development, construction and operation of Spanish solar photovoltaic assets and currently has 50MW of assets in development across twelve projects spanning central and southern Spain.

Aquila Capital is a private investment firm based in Hamburg, Germany, founded in 2001. It specializes in providing institutional investors, pension funds, foundations, and individuals with alternative investment solutions across real assets, financial markets, and private equity. The firm employs a multi-disciplinary investment approach, leveraging a team of dedicated specialists to manage a diverse range of investments, including hedge funds, private equity fund of funds, real estate, and infrastructure projects. Aquila Capital emphasizes strong operational frameworks and corporate governance to enhance its investment management capabilities. The firm operates additional offices in Frankfurt, Munich, and Vienna, and aims to identify and manage attractive investment opportunities for its clients through a solution-oriented approach that encompasses strategy development, implementation, and asset management.

Opdenergy is an independent renewable energy producer with over 15 years of experience, specializing in solar photovoltaic and onshore wind energy. The company operates projects across several countries, including Spain, Chile, Italy, Mexico, and the USA, with the majority of its revenue generated from the Spanish market. Opdenergy's diverse portfolio reflects its commitment to advancing renewable technologies and contributing to sustainable energy solutions.

Iberdrola is a leading global utility company engaged in the production, distribution, and retail of electricity and gas across nearly 40 countries. With a diverse portfolio of 56 gigawatts, it primarily generates electricity from nuclear, fossil-fuel, hydroelectric, and renewable energy sources, with wind power representing approximately 40% of its capacity. The company operates significant electricity and distribution networks in Spain, the UK, Brazil, and the US, where it maintains a strong presence. Iberdrola is committed to advancing the energy transition through a sustainable business model that emphasizes renewable energy, smart grids, large-scale energy storage, and digital transformation, aimed at delivering innovative products and services to its customers. In addition to its generation activities, Iberdrola is involved in gas storage and supply, reinforcing its position as a comprehensive energy provider.

Blickfeld is a Munich-based company that specializes in producing LiDAR sensors and detection software for autonomous mobility and Internet of Things (IoT) applications. Founded in 2017, Blickfeld's technology utilizes patented silicon MEMS mirrors along with commercial off-the-shelf components to create cost-effective laser range scanners. These sensors are designed to measure direct distance information in three dimensions, enabling high-definition geometric mapping and object detection. Blickfeld's innovative approach allows for the mass production of low-cost LiDAR systems that meet stringent automotive performance standards, making advanced technology accessible for the autonomous driving market.

Loci Orthopaedics Limited, based in Upper Newcastle, Ireland, specializes in developing innovative medical technologies to address significant unmet clinical needs in orthopedics. Founded in 2017, the company focuses on creating surgical implants, particularly the InDx implant, which is designed to treat arthritis in the thumb base joint. This implant uniquely mimics the natural motions of the thumb joint, offering a less invasive and easier insertion method compared to existing surgical options. Additionally, Loci Orthopaedics is known for its Osteoanchor surface architecture, which is based on evidence-based designs, enabling clinicians to effectively address challenges in orthopedic extremities.

Nomagic, Inc. is a company based in Warsaw, Poland, specializing in robotic manipulation solutions for order fulfillment in e-commerce warehouses. By providing smart pick-and-place robotic systems, Nomagic enhances efficiency, flexibility, and reliability in the logistics process. Their technology automates repetitive tasks, reduces fulfillment costs, and addresses labor shortages, allowing warehouses to operate seamlessly around the clock. The company's robots have already been implemented on packing lines at Cdiscount, a leading French e-commerce platform. Utilizing artificial intelligence, Nomagic's systems continuously learn and adapt to changing conditions, improving the agility of warehouse operations and ensuring reliable delivery of goods.

Inventiva Pharma is a clinical-stage biopharmaceutical company based in France, dedicated to developing oral small molecule therapies for patients with significant unmet medical needs, particularly in fibrosis, lysosomal storage disorders, and oncology. The company specializes in drugs that target nuclear receptors, transcription factors, and epigenetic modulation. Its primary product candidate, lanifibranor, is being developed for the treatment of non-alcoholic steatohepatitis (NASH), a condition currently lacking approved therapies. Inventiva has established a robust pipeline supported by a proprietary discovery engine, a dedicated research and development facility, and a skilled team with extensive experience in drug development. In addition to advancing lanifibranor, the company is also working on several earlier-stage programs aimed at addressing various medical conditions. All operations are conducted in France.

Cabify is a ride-sharing company founded in 2011 and headquartered in Madrid, Spain. It connects private users and businesses with transportation options that meet their needs, focusing on enhancing the overall travel experience for both passengers and drivers. The company offers on-demand services that include clean, modern vehicles equipped with amenities such as music, magazines, and water, all driven by specially trained drivers. Cabify emphasizes affordability, safety, and reliability in its rides, aiming to improve mobility in urban areas and contribute positively to the communities it serves. By prioritizing customer satisfaction and accessibility, Cabify seeks to redefine transportation in cities.

Airborne International is engaged in engineering, manufacturing, and supplying high-end composites structures for industries such as aerospace, defense, marine, high-end bicycles, and formula-one cars. It offers composites structures maintenance and repair services, including inspection and damage assessment, sealing and painting, and balancing. The company was founded in 1995 and is based in The Hague, the Netherlands.

InstaFreight GmbH is a Berlin-based company that specializes in providing online freight forwarding services to B2B customers. Founded in 2016, InstaFreight aims to simplify the booking and processing of freight transport, making it fast and straightforward for businesses. The company focuses on delivering reliability, quality, and transparency, striving to become Europe's leading online freight forwarder. By offering innovative solutions and exceptional service, InstaFreight reduces the complexity of supply chains and enhances transparency for both customers and carriers.

Priothera Ltd is a clinical-stage company based in Dublin, Ireland, with an additional location in Saint Louis, France. It specializes in the development of orally applied sphingosine 1 phosphate (S1P) receptor modulators aimed at treating haematological malignancies. The company's primary focus is on its lead product, mocravimod, which is designed to enhance the curative potential of allogeneic haematopoietic stem cell transplants. By reducing the egress of T cell subsets from lymphatic tissues, Priothera's modulators aim to provide dual inhibition of graft versus host disease while also promoting graft versus leukemia effects, ultimately improving patient outcomes in this challenging area of medicine.

TRUMPF is a high-technology company based in Ditzingen, Germany, specializing in the manufacturing of machine tools, industrial lasers, and medical technologies. Renowned as a leader in flexible sheet metal processing, TRUMPF is committed to advancing digital connectivity within the manufacturing industry through innovative consulting, platforms, and software solutions. As a family-owned enterprise, it emphasizes long-term thinking and sustainable growth, bolstering its reputation for continuous innovation. TRUMPF Venture, the company's corporate venture capital arm, aims to foster innovation by investing globally in early-stage startups that align with TRUMPF's core business areas, including photonics, manufacturing technology, and industrial software systems. The venture arm seeks companies with a strategic fit, strong management teams, and potential for significant market differentiation, providing these startups access to TRUMPF's extensive network and expertise to enhance their scalability and success.

DPG Media is a media company based in Antwerp, Belgium, specializing in the publication of newspapers, journals, and magazines. It offers a diverse range of content, including news on entertainment, sports, politics, and market trends, catering to various interests and demographics. In addition to its publishing activities, DPG Media provides advertising services, allowing businesses to reach a wider audience through its platforms. The company is dedicated to delivering informative and engaging stories while contributing to the media landscape in Belgium.

Starship Technologies, Inc. is a robotics company that specializes in the design and manufacture of self-driving delivery robots intended for local goods transportation. Founded in 2014, the company is headquartered in London, United Kingdom, with a research and development center in Estonia. Its autonomous robots are capable of delivering parcels, groceries, and food within a 30-minute timeframe, operating autonomously 99% of the time. These robots utilize a suite of sensors, including cameras and GPS, to ensure safe and efficient curb-side deliveries from local hubs. Starship Technologies aims to revolutionize the delivery process by providing convenient services that enhance everyday life while promoting environmentally friendly practices and reducing costs associated with local deliveries.

miDiagnostics is a Belgian company focused on creating innovative, chip-based technology for self-administered blood analysis. The company is developing a new generation of disposable tests that require only small drops of blood, allowing for the detection of various biomarkers, including cells, proteins, nucleic acids, and small molecules. Their technology integrates a nanofluidic processor on a chip with a compact reader, facilitating lab-quality diagnostics from easy-to-access samples like finger-prick blood or nasal swabs. This approach enables both patients and clinicians to conduct rapid diagnostics conveniently and efficiently, regardless of location.

Stilla Technologies is a biotechnology company based in Villejuif, France, with an additional location in Beverly, Massachusetts. Founded in 2013, the company specializes in accelerating the development of next-generation genetic tests through its innovative digital PCR (dPCR) solution, the Naica System. This platform leverages advanced microfluidic technology to provide a flexible and accessible tool for high-resolution genetic analysis. By enabling compatibility with multiple chemistries and offering multiplex capabilities, Stilla Technologies aims to simplify the processes of image analysis and data exploration for researchers in various fields, including life sciences and therapeutics. The company's mission is to make digital PCR a standard tool across all areas of genetic research and application.

Xeltis is a clinical-stage medical device company focused on transforming cardiovascular treatment through innovative restorative technologies. The company has developed advanced polymer-based devices, including bioabsorbable heart valves and implantable small diameter blood vessels, intended for hemodialysis vascular access and coronary artery bypass graft surgery. These devices leverage proprietary technology to facilitate endogenous tissue restoration, allowing the body to naturally regenerate the complex structures being replaced. Xeltis emerged from the merger of two university spin-offs from the Netherlands and Switzerland and operates in both the Netherlands and the USA. The company is backed by several venture capital firms and has secured significant funding from the European Investment Bank and the European Innovation Council Accelerator. Currently, Xeltis is conducting ongoing clinical trials to advance its restorative cardiovascular solutions.

University College Dublin is one of Europe's leading research-intensive universities. At UCD undergraduate education, master's and PhD training, research, innovation and community engagement form a dynamic spectrum of activity. Today UCD is Ireland's largest and most diverse university with over 30,000 students, drawn from approximately 124 countries. It actively promotes university life as a journey of intellectual and personal discovery through its highly innovative and flexible UCD Horizons undergraduate curriculum and is the most popular destination for Irish school-leavers. UCD is Ireland’s leader in graduate education with approximately 7,000 graduate students, and almost 2,000 PhD students. Over 50% of UCD undergraduates progress to graduate studies.

Ørsted is a Danish company specializing in the development and maintenance of offshore and onshore renewable energy farms, energy storage facilities, and bioenergy plants. Formerly known as DONG Energy, Ørsted has undergone a significant transformation over the past decade, committing to a vision of a world powered entirely by green energy. The company has dramatically reduced its coal consumption by 73% and aims to completely phase out coal by 2023. As a global leader in offshore wind, Ørsted holds a 25% market share, providing energy to approximately 9.5 million people. By the end of 2023, Ørsted operated 8.9 gigawatts of offshore wind capacity, with the United Kingdom being its largest market, followed by Germany and Denmark. The company is also expanding its presence outside Europe with projects in Taiwan and the United States, where it operates 4.8 gigawatts of onshore wind and solar assets. In addition to its renewable initiatives, Ørsted still engages in traditional utilities, including conventional power plants.

OSE Immunotherapeutics SA is a clinical-stage biotechnology company based in Nantes, France, specializing in the development of innovative immunotherapies aimed at immune activation and regulation, particularly in the areas of immuno-oncology and autoimmune diseases. The company's product portfolio includes Tedopi, which is in Phase III clinical trials for lung cancer and Phase II for pancreatic cancer; BI 765063, currently in Phase I trials for solid tumors; and OSE-703, a humanized monoclonal antibody in preclinical development for various cancers. Additionally, OSE Immunotherapeutics is advancing FR104, which is in Phase I trials for rheumatoid arthritis, and OSE-127, a humanized monoclonal antibody in Phase I trials for inflammatory autoimmune diseases. The company collaborates with notable partners such as GERCOR, Memorial Sloan Kettering Cancer Center, Boehringer Ingelheim, Servier, and HalioDx. OSE Immunotherapeutics was previously known as OSE Pharma SA before its name change in May 2016.

Bouygues Telecom is a prominent telecommunications operator in France, offering a wide range of services that include mobile, fixed-line, television, internet, and cloud computing. The company serves approximately 11.1 million mobile customers and 2.1 million fixed broadband customers, including over 1.5 million professional and corporate clients. Renowned for its innovative approach, Bouygues Telecom has introduced several pioneering products, such as the first unlimited call plans, fixed-mobile convergence offers for corporate customers, and the quadruple play solution known as ideo. The company also launched B&YOU, a web-only offer that revolutionized mobile telephony. With a mobile network that covers 99% of the population and a rapidly expanding 4G network, Bouygues Telecom is committed to enhancing customer experience through its dedicated team of over 9,000 employees and a robust customer service framework that includes 2,000 advisers and 2,500 sales staff. The company's focus on innovation and customer satisfaction positions it as a key player in the French telecommunications market.

Spire Global, Inc. is a provider of satellite data services that specializes in delivering unique datasets and analytics to a variety of organizations. The company offers products such as Spire Sense, which tracks maritime activities for purposes including trade monitoring and search and rescue, and Spire Stratus, which provides global weather data. Spire utilizes one of the largest multi-purpose satellite constellations to gather valuable information that is enhanced with predictive analytics. This data is available via subscription to clients in sectors like mining, government, and maritime operations, enabling them to optimize business processes, reduce environmental impact, and manage risks effectively. Founded in 2012 and based in San Francisco, Spire also has offices in Glasgow and Singapore, positioning itself as a key player in the space-based data analytics market.

Worldsensing is a leading provider of Internet of Things (IoT) solutions, specializing in low-power wireless sensing networks. The company has developed comprehensive applications for smart cities and industrial sectors, focusing on mobility and industrial solutions. Its mobility portfolio includes Bitcarrier, a real-time traffic flow management system, and Fastprk, a widely recognized smart parking solution. In industrial applications, Worldsensing offers the LS-G6 platform, which monitors assets in challenging locations such as bridges, tunnels, and power lines. Founded in 2010, the company has secured funding through various investment rounds, with notable contributions from Fundación Jose Manuel Entrecanales and Kibo Ventures. Worldsensing has received multiple accolades for its innovations, including awards for Fastprk and Bitcarrier, and its CEO, Ignasi Vilajosana, was named the first Spanish Endeavor Entrepreneur in 2014. With offices in Barcelona and London, the company employs a team of over 40 professionals dedicated to enhancing infrastructure through advanced sensing technologies.

Robart is an Austrian high-tech start-up established in 2009, dedicated to creating autonomous mobile robots for both consumer and industrial use, leveraging its proprietary Artificial Intelligence Control Unit (AICU) technology. The company aims to revolutionize everyday life by developing affordable robotic solutions, including intelligent vacuum cleaners and security robots, that can effectively navigate and adapt to dynamic home environments. By focusing on robust functionality and intuitive user interaction, Robart addresses the shortcomings of current robotic offerings, ensuring that its products not only meet but exceed consumer expectations. The company's innovative approach positions it as a key player in the next generation of intelligent robotics, with a vision of making a robot accessible for every household.

Magazino GmbH, founded in 2014 and based in Munich, Germany, specializes in developing and manufacturing mobile robots for the storage and intralogistics sectors. The company offers advanced mobile pick-and-place robots designed for e-commerce warehouses, capable of identifying and localizing individual items using 2D and 3D cameras. These robots operate collaboratively as part of a swarm, utilizing the ACROS (Advanced Cooperative Robot Operating System) to receive and execute orders. Additionally, Magazino provides the App ARC (ACROS Robot Control) for monitoring robot fleets. Their technology aims to simplify and automate daily operations for mail-order companies, warehouses, production lines, and pharmacies, ultimately contributing to the evolution of robotics and the future of logistics.

ESB International is an engineering consultancy that specializes in energy utilities and energy supply, catering to business developers. As one of Europe's leading organizations in this field, it operates in the non-regulated sectors of ESB and extends its services globally. The company offers a range of services, including engineering design, construction management, and strategic consultancy, primarily serving clients in Ireland as well as the power sector worldwide. Through its expertise, ESB International plays a significant role in advancing energy solutions and supporting the development of energy infrastructure.

Advicenne is a late-stage biopharmaceutical company founded in 2007 and headquartered in Nîmes, France. The company focuses on developing and commercializing innovative treatments for unmet medical needs in nephrology, particularly targeting orphan renal diseases and niche neurology indications. Its lead drug candidate, ADV7103, is undergoing late-stage clinical trials for two specific conditions: distal renal tubular acidosis (dRTA) and cystinuria. Advicenne aims to create pediatric-friendly therapeutics that enhance the lives of patients from early childhood through adulthood.

NavVis is a technology company based in Munich, Germany, specializing in indoor spatial intelligence and digital twin solutions. The company offers mobile mapping systems that utilize simultaneous localization and mapping (SLAM) technology to generate high-quality, survey-grade data quickly and efficiently. Its platform is designed to assist service providers and enterprises in capturing and sharing the built environment as photorealistic digital twins, enabling better operational decisions and increased productivity. NavVis's digital factory solutions facilitate improved business processes and profitability for clients in industries such as surveying, architecture, engineering, construction, and manufacturing. With additional offices in the United States and China, NavVis serves a global customer base, providing tools for accurate 3D mapping and immersive visualization of industrial facilities.

Iberdrola is a leading global utility company engaged in the production, distribution, and retail of electricity and gas across nearly 40 countries. With a diverse portfolio of 56 gigawatts, it primarily generates electricity from nuclear, fossil-fuel, hydroelectric, and renewable energy sources, with wind power representing approximately 40% of its capacity. The company operates significant electricity and distribution networks in Spain, the UK, Brazil, and the US, where it maintains a strong presence. Iberdrola is committed to advancing the energy transition through a sustainable business model that emphasizes renewable energy, smart grids, large-scale energy storage, and digital transformation, aimed at delivering innovative products and services to its customers. In addition to its generation activities, Iberdrola is involved in gas storage and supply, reinforcing its position as a comprehensive energy provider.

CureVac is a clinical-stage biopharmaceutical company based in Germany, focused on developing vaccines and therapies utilizing messenger RNA (mRNA). Founded in 2000, the company’s innovative approach involves using mRNA as a data carrier to instruct the body to produce proteins that can combat various diseases. CureVac's pipeline includes novel mRNA-based cancer immunotherapies, prophylactic vaccines for infectious diseases, and molecular therapies aimed at enhancing the body’s production of therapeutic proteins. Its most advanced candidate, CV9104, is currently in Phase IIb clinical trials for prostate cancer treatment. Additionally, CureVac has collaborated with GSK to create second-generation vaccines for seasonal influenza and COVID-19, as well as an avian influenza vaccine, while exploring other mRNA vaccine applications in oncology and various therapeutic areas.

BioNTech is a biotechnology company based in Germany that specializes in developing innovative therapies for cancer and infectious diseases, including COVID-19. The company is known for its focus on individualized immunotherapy and has a diverse oncology pipeline that features various classes of drugs, such as mRNA-based therapeutics that encode antigens and neoantigens, as well as cytokines, antibodies, cell therapies, bispecific antibodies, and antibody-drug conjugates. BioNTech's notable achievement includes the commercialization of its COVID-19 vaccine, Comirnaty. Additionally, the company collaborates with several major pharmaceutical firms, enhancing its capabilities and reach in the biopharmaceutical industry.

AM Pharma B.V. is a biopharmaceutical company based in Bunnik, the Netherlands, focused on developing and commercializing novel therapeutics for inflammatory and infectious diseases. Established in 2000, the company specializes in pre-clinical and clinical development using endogenous proteins and peptides derived from the human body. Its key products include alkaline phosphatase, aimed at treating acute kidney injury and ulcerative colitis, and the immune response amplifying peptide hLF1-11, which targets drug-resistant hospital-acquired infections. AM Pharma is committed to providing innovative therapies that enhance patient quality of life by addressing critical medical needs.

ITM Isotopen Technologien München AG is a privately held biotechnology and radiopharmaceutical group of companies dedicated to the development, production and global supply of targeted diagnostic and therapeutic radiopharmaceuticals and radionuclides for use in cancer treatment. Since its foundation in 2004, ITM and its subsidiaries have established GMP manufacturing and a robust global supply network of a novel, first-in-class medical radionuclides and -generator platform for a new generation of targeted cancer diagnostics and therapies. ITM’s isotope business is profitable and growing. In July 2016 the European Commission has granted Marketing Authorization for EndolucinBeta® of ITM´s subsidiary ITG Isotope Technologies Garching GmbH. EndolucinBeta® respectively no-carrier-added (n.c.a.) Lutetium (177Lu) chloride is a radiopharmaceutical precursor and is used in Targeted Radionuclide Therapy. The drug approval is an important milestone for ITM as a specialized radiopharmaceutical company. Furthermore, ITM is developing a proprietary portfolio and growing pipeline of targeted treatments in various stages of clinical development, which address a range of cancers such as neuroendocrine cancers or bone metastases. ITM’s main objectives, together with its scientific, medical and industrial collaboration partners worldwide, are to significantly improve outcomes and quality of life for cancer patients while at the same time reducing side effects and improving health economics through a new generation of Targeted Radionuclide Therapies in Precision Oncology.

Telefónica Deutschland offers mobile and fixed services for private and business customers, as well as innovative digital products and services in the fields of Internet of Things and data analytics. With a total of 49.6 million1) customer lines, the company is one of the leading integrated telecommunications providers. In the mobile segment alone, Telefónica Deutschland is responsible for more than 45 million1) lines. Telefónica Deutschland will become the "Mobile Customer & Digital Champion" – with this aspiration, the company intends to become the preferred customer partner in the German mobile service market by 2022. This is linked to a clear mandate that Telefónica Deutschland will make its customers’ lives easier and better and allows them mobile freedom in the digital world. In concrete terms, this means a consistently positive experience with the brand, products, customer service and network. The company already has an excellent foundation to reach this goal. No network operator in Germany connects more people with mobile services. Following the integration of E-Plus, the company is digitalising its business model while consistently focusing on customer benefit.

On Robot manufactures robot equipment for automation tasks throughout the industry. It provides plug and produce end-of-arm tools and software solutions that help manufacturers take full advantage of the benefits of collaborative robots. The company integrates grippers, sensors, and other cobot equipment to facilitate the use of technology in applications such as packaging, quality testing, material handling, machine tending, assembly, and welding. On Robot was founded in 2015 and is based in Odense, Denmark.

Median Technologies SA specializes in the development and marketing of software products and platforms for medical image analysis, primarily focusing on oncology. Founded in 2002 and headquartered in Valbonne, France, the company operates internationally, offering solutions that enhance the diagnosis and treatment of cancer patients. Its key products include iBiopsy, an imaging platform that utilizes AI for biomarker identification, and iSee, which supports image analysis and management in clinical trials. Additionally, Median provides a range of imaging contract research services, including study startup, data management, and scientific consulting to optimize clinical trials. The company collaborates with a contract research organization and Canon to enhance its imaging technologies and services, aiming to improve patient care and streamline drug development processes.

BioNTech is a biotechnology company based in Germany that specializes in developing innovative therapies for cancer and infectious diseases, including COVID-19. The company is known for its focus on individualized immunotherapy and has a diverse oncology pipeline that features various classes of drugs, such as mRNA-based therapeutics that encode antigens and neoantigens, as well as cytokines, antibodies, cell therapies, bispecific antibodies, and antibody-drug conjugates. BioNTech's notable achievement includes the commercialization of its COVID-19 vaccine, Comirnaty. Additionally, the company collaborates with several major pharmaceutical firms, enhancing its capabilities and reach in the biopharmaceutical industry.

Orange is a digital operator that offers mobile and internet services in Europe and Africa, and corporate telecommunication services worldwide. The group operates under the brand name Orange Business Services, both in France and internationally, in the business communication and IT services markets. Orange Business Services offers a range of services to large corporates, local authorities, and SMEs in France, as well as to multinationals around the world, supporting the implementation of their communication projects. To do so, OBS offers a full range of voice and data, IT, and integrated services. The Orange Fabs is an international network of startup drivers that provides startups in the digital space with advice, training, and events, as well as resources and expertise. Orange was founded in 1991 and is headquartered in Paris, France with a presence in 30 countries.

Bitmovin Inc specializes in online streaming solutions and server encoding systems, focusing on enhancing the performance and delivery of video content. Founded in 2012, the company offers a cloud-based transcoding platform known as bitcodin, which supports adaptive streaming formats like MPEG-DASH and Apple HLS. Its product suite includes BITDASH, optimized clients for various platforms, and LIBDASH, an official ISO/IEC MPEG-DASH reference software. Additionally, Bitmovin provides an Encoding API for real-time content encoding, a Player for delivering video to devices, and Analytics tools to improve viewer engagement through actionable insights. With offices in San Francisco and Klagenfurt, Austria, Bitmovin also engages in consulting and standardization services related to multimedia technologies, leveraging a strong connection to academic research in the field. The company has formed a strategic partnership with Intertrust Technologies Corporation and is backed by notable investors.

ISA Pharmaceuticals B.V. is a clinical-stage immunotherapy company based in Leiden, the Netherlands, established in 2004. The company specializes in developing synthetic long peptide-based therapies aimed at addressing unmet medical needs in cancer and persistent viral infections. Utilizing its proprietary Synthetic Long Peptide (SLP®) platform and AMPLIVANT® technology, ISA Pharmaceuticals designs fully synthetic immunotherapeutics that aim to engage and enhance the body’s immune response against diseases. These innovative therapies are intended to be effective either as standalone treatments or in combination with existing therapies, thereby improving the likelihood of successful patient outcomes.

FAZUA GmbH is a company that develops and manufactures innovative e-bike drive systems, aiming to enhance cycling mobility while preserving the natural feel of traditional biking. Founded in 2011 and headquartered in Munich, Germany, FAZUA's flagship product, the evation drive system, integrates an engine, gearbox, battery, and power electronics that can be easily removed and replaced with a cover. This design allows bike manufacturers to create sleek frames that discreetly house the drive system in the downtube. The company focuses on meeting the demands of sporty cyclists while providing a seamless transition between motorized and non-motorized riding experiences.

Vivasure Medical Limited is a medical device company based in Galway, Ireland, specializing in the research, development, and manufacture of arterial and venous closure devices utilizing its patented PerQseal technology. The company focuses on creating polymer implants and delivery systems aimed at minimally invasive vessel closures in the fields of cardiology, interventional radiology, and vascular surgery. Its primary product is a large-bore percutaneous closure device that employs an absorbable patch to effectively close large arteriotomies following transcatheter procedures, including transcatheter aortic valve replacement and endovascular aneurysm repair. Established in 2008, Vivasure Medical is dedicated to advancing medical solutions that enhance patient outcomes in vascular access procedures.

FlixBus, operated by FlixMobility, is a notable provider of intercity travel, focusing on affordable, convenient, and environmentally-friendly transportation solutions. Since its inception in 2013, the company has established Europe's largest long-distance bus network and introduced green long-distance trains in 2018, alongside a pilot for all-electric buses in Germany and France. The platform offers travelers a sustainable alternative to private transportation, featuring amenities such as free WiFi, flexible online booking, and innovative ticketing systems. FlixBus also expanded its services to the United States in 2018, bringing its unique travel model to a broader audience. By collaborating with regional bus partners and private train companies, FlixMobility combines technological innovation with traditional transportation expertise, positioning itself as a leader in the evolving mobility landscape. As a result, FlixBus has transformed the travel experience for over 100 million people across Europe and the United States while contributing to job creation in the mobility sector.

Trinity College is a research university and the sole constituent college of the University of Dublin in Ireland. It offers various degree and diploma courses at both undergraduate and postgraduate levels. The college is home to a diverse student population and a range of academic disciplines.

Curetis AG, founded in 2015 and based in Holzgerlingen, Germany, develops molecular diagnostics solutions aimed at detecting infectious diseases, pathogens, and antibiotic resistance markers. The company specializes in multiparameter testing, enabling the simultaneous analysis of various analytes in a single run. Its primary focus is on providing comprehensive panels for detecting severe bacterial infections, offering rapid diagnostic solutions that help physicians obtain early and actionable insights in managing infectious diseases and antimicrobial resistance. Curetis operates as a subsidiary of OpGen, Inc. and is positioned to expand its diagnostic capabilities into other clinical applications beyond infectious diseases in the future.

Mobidiag is a Finnish-French biotechnology company that focuses on developing and marketing innovative molecular diagnostic solutions aimed at detecting gastrointestinal infections, antimicrobial resistance, healthcare-associated infections, respiratory infections, and sepsis. Utilizing established qPCR and microarray technologies, Mobidiag provides a wide array of fast, reliable, and cost-effective diagnostic tests and automated platforms suitable for laboratories of various sizes. Their offerings enable the detection of a broad spectrum of clinically relevant bacteria, parasites, viruses, and antibiotic resistance markers, thereby facilitating quicker diagnosis and treatment in hospitals, laboratories, and clinics.

Aerogen Limited is a medical device and drug delivery company based in Galway, Ireland, specializing in aerosol drug delivery systems for the critical care respiratory market. Founded in 1997, Aerogen has developed a range of innovative products, including the Aerogen Solo, Ultra, Pro, and Go nebulizers, which are designed for various patient needs, from those on life-support ventilation to home care settings. The company's patented Vibronic aerosol technology enables the efficient nebulization of medication into fine particles, ensuring effective delivery while preserving drug integrity. Aerogen’s products are used in over 65 countries worldwide, reflecting its leading position in acute care aerosol drug delivery. With a strong emphasis on research and development, the company continually seeks to advance its product offerings through strategic collaborations with prominent research institutions. Aerogen's workforce is highly educated, with a significant percentage holding degrees in science and engineering, contributing to its commitment to innovation and excellence in respiratory care.

CARMAT is a France-based medtech company that specializes in the development and manufacture of bioprosthetic artificial hearts aimed at treating patients with severe heart failure. Founded in 2008 and located in Vélizy-Villacoublay, the company produces biocompatible and auto-regulated total artificial hearts that closely mimic the human heart's functionality. These devices are designed for individuals experiencing chronic terminal heart failure classified as NYHA class IV or those suffering from acute terminal heart failure following a major heart attack. CARMAT's innovative solutions target patients who are not suitable for heart transplantation and have exhausted other treatment options, providing a reliable new therapeutic alternative. In addition to the artificial hearts, CARMAT also develops the associated power supply and control systems, including remote diagnosis capabilities.

F2G Ltd is a biotechnology company based in Manchester, United Kingdom, that specializes in developing innovative therapies for serious fungal diseases. Established in 1998, F2G focuses on its F3 series of antifungal compounds, particularly targeting challenging fungi such as Aspergillus and other filamentous molds that pose significant health risks. The company leverages its proprietary genomics technology, MycoBank, to identify critical gene targets in fungi, facilitating the creation of effective antifungal agents. Since its initial funding in 2002, F2G has expanded its research and development capabilities, enabling it to advance its patented compounds and contribute to addressing life-threatening fungal infections that affect individuals with compromised immune systems.

Mobidiag is a Finnish-French biotechnology company that focuses on developing and marketing innovative molecular diagnostic solutions aimed at detecting gastrointestinal infections, antimicrobial resistance, healthcare-associated infections, respiratory infections, and sepsis. Utilizing established qPCR and microarray technologies, Mobidiag provides a wide array of fast, reliable, and cost-effective diagnostic tests and automated platforms suitable for laboratories of various sizes. Their offerings enable the detection of a broad spectrum of clinically relevant bacteria, parasites, viruses, and antibiotic resistance markers, thereby facilitating quicker diagnosis and treatment in hospitals, laboratories, and clinics.

tado° GmbH is a Munich-based company that specializes in developing and marketing home climate control systems. Founded in 2010, the company offers a combination of hardware and software solutions designed to enhance the efficiency of heating and cooling systems in residential and small business environments. tado°'s innovative products adjust to the behavior of residents in real time while also considering weather forecasts and building characteristics. The company distributes its offerings through both retail stores and online platforms, positioning itself at the intersection of technology and sustainable energy management in the cleantech market. With an additional office in London, tado° continues to focus on integrating Internet of Things technology into everyday climate control solutions.

Trinity College is a research university and the sole constituent college of the University of Dublin in Ireland. It offers various degree and diploma courses at both undergraduate and postgraduate levels. The college is home to a diverse student population and a range of academic disciplines.

Nokia is a Finnish multinational communications corporation that specializes in manufacturing mobile devices, network infrastructure, and advanced technologies. The company offers a diverse range of products and services designed to enhance communication and connectivity, including mobile broadband, global services, location-based technologies, and technology licensing. Its mobile broadband segment provides essential hardware and core network software for mobile voice and data services, while the global services segment focuses on network implementation, management, and optimization. Nokia's HERE segment is dedicated to developing local commerce and location-based services. The company operates in over 150 countries and has significant manufacturing facilities in locations such as India, China, Finland, and Germany. Additionally, Nokia maintains a robust research division and a patent business, contributing to its role as a key player in the telecommunications industry.